Insider · CIK 0002004480
Kaufman Beth Zelnick
Files at CRMD (CorMedix Inc.). First filing Sep 11, 2025, latest Sep 11, 2025.
In brief
Kaufman Beth Zelnick files SEC Form 4 as officer at CRMD (CorMedix Inc.). Since Sep 11, 2025, Kaufman Beth Zelnick has reported 0 open-market buys worth $0 and 1 open-market sell worth $670k, the latest filed on Sep 11, 2025.
A track record needs three past buys with six months of prices behind them; Kaufman Beth Zelnick has 0, so none is measured yet.
The newest scored trade: sold $670k of CRMD on Sep 9, 2025, filed Sep 11, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRMD: CorMedix Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | CorMedix Inc. | $670k 50,000 shares | -22% | +122% from low-21% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 9, 2025 | CRMD CorMedix Inc. | 50,000 0.07% of outstanding | $673k | Sep 9, 2025 | none |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 29, 2026 | CRMD CorMedix Inc. | FTax withholding Common Stock | -8,424 | $8.30 | $70k | 260,684 | 42 d ago |
| Feb 4, 2026 | CRMD CorMedix Inc. | AGrant or award Common Stock | +36,006 | $0.00 | $0 | 269,108 | Feb 6, 2026 |
| Jan 23, 2026 | CRMD CorMedix Inc. | AGrant or award Common Stock | +72,820 | $0.00 | $0 | 241,905 | Jan 27, 2026 |
| Jan 23, 2026 | CRMD CorMedix Inc. | FTax withholding Common Stock | -8,803 | $7.27 | $64k | 233,102 | Jan 27, 2026 |
| Jan 2, 2026 | CRMD CorMedix Inc. | FTax withholding Common Stock | -11,333 | $12.16 | $138k | 169,085 | Jan 6, 2026 |
| Sep 9, 2025 | CRMD CorMedix Inc. | MOption exercise Common Stock | +50,000 | $3.30 | $165k | 230,418 | Sep 11, 2025 |
| Sep 9, 2025 | CRMD CorMedix Inc. | SOpen-market sale Common Stock | -49,600 | $13.41 | $665k | 180,818 | Sep 11, 2025 |
| Sep 9, 2025 | CRMD CorMedix Inc. | SOpen-market sale Common Stock | -400 | $12.82 | $5,128 | 180,418 | Sep 11, 2025 |
| Sep 9, 2025 | CRMD CorMedix Inc. | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -50,000 | $0.00 | $0 | 150,000 | Sep 11, 2025 |
| Aug 29, 2025 | CRMD CorMedix Inc. | FTax withholding Common Stock | -8,880 | $14.83 | $132k | 180,418 | Sep 8, 2025 |
| Aug 29, 2025 | CRMD CorMedix Inc. | AGrant or award Common Stock | +69,686 | $0.00 | $0 | 189,298 | Sep 3, 2025 |
| Jan 2, 2025 | CRMD CorMedix Inc. | AGrant or award Common Stock | +87,500 | $0.00 | $0 | 131,456 | Jan 6, 2025 |
| Jan 2, 2025 | CRMD CorMedix Inc. | FTax withholding Common Stock | -11,844 | $8.22 | $97k | 119,612 | Jan 6, 2025 |
| Dec 12, 2024 | CRMD CorMedix Inc. | FTax withholding Common Stock | -6,044 | $8.77 | $53k | 43,956 | Dec 18, 2024 |
| Dec 12, 2024 | CRMD CorMedix Inc. | MOption exercise Common Stock | +12,500 | - | - | 62,500 | Dec 16, 2024 |
| Dec 12, 2024 | CRMD CorMedix Inc. | FTax withholding Common Stock | -6,044 | $8.77 | $53k | 56,456 | Dec 16, 2024 |
| Dec 12, 2024 | CRMD CorMedix Inc. | MOption exercise Restricted Stock Unitsderivative | -12,500 | $0.00 | $0 | 37,500 | Dec 16, 2024 |
| Dec 12, 2023 | CRMD CorMedix Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 50,000 | Dec 14, 2023 |
| Dec 12, 2023 | CRMD CorMedix Inc. | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +200,000 | $0.00 | $0 | 200,000 | Dec 14, 2023 |
Questions about Kaufman Beth Zelnick
Answered from the filings on this page, as of the latest one.
Is Kaufman Beth Zelnick buying or selling?
Not in the last 12 months. Kaufman Beth Zelnick's latest open-market trade on SEC Form 4 was sold $670k of CRMD on Sep 9, 2025.
How did Kaufman Beth Zelnick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kaufman Beth Zelnick has 0.
Where does Kaufman Beth Zelnick file Form 4?
Kaufman Beth Zelnick has filed Form 4 at CRMD (CorMedix Inc.) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.